Latest Leadership News

Page 17 of 429
Murray Cod Australia (ASX:MCA) has launched the retail tranche of its fully underwritten $18.6 million entitlement offer at a 43% discount, aiming to convert its record 3,700-tonne biomass into cash and expand processing capacity.
Victor Sage
Victor Sage
8 May 2026
QBE Insurance Group kicked off 2026 with robust premium growth and solid underwriting, maintaining its full-year guidance amid geopolitical uncertainty and evolving risks.
Victor Sage
Victor Sage
8 May 2026
Neometals is pivoting towards gold production with a funded JV at its Barrambie Ironclad deposit, while simultaneously progressing a substantial lithium-potash brine project in Utah.
Maxwell Dee
Maxwell Dee
8 May 2026
REA Group delivered robust Q3 FY26 results, driven by double-digit revenue growth in Australia and record engagement on realestate.com.au, while lowering its cost growth guidance for FY26.
Sophie Babbage
Sophie Babbage
8 May 2026
Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.
Ada Torres
Ada Torres
7 May 2026
Promisia Healthcare’s portfolio value jumps 17.1% to $107.2 million, driven by improved occupancy and operational efficiencies across all sites.
Ada Torres
Ada Torres
7 May 2026
Proteomics International Laboratories (ASX:PIQ) has denied any undisclosed material information following a sharp share price drop and heightened trading activity, pointing instead to recent strategic updates and organisational changes.
Ada Torres
Ada Torres
7 May 2026
Tali Resources has raised $3 million through a discounted share placement to bankroll a multi-phase drilling campaign at its West Arunta Project, aiming to capitalise on recent geophysical advances.
Maxwell Dee
Maxwell Dee
7 May 2026
Boom Logistics has upgraded its FY26 earnings guidance, anticipating a 31% rise in statutory EPS, backed by $7 million in new contracts across energy and mining sectors.
Victor Sage
Victor Sage
7 May 2026
ARN Media reported a 10% revenue decline in FY25 but accelerated digital growth and cost savings, while defending ongoing legal disputes with former talent.
Elise Vega
Elise Vega
7 May 2026
Zip Co’s April update highlights robust US and ANZ market expansion, with total transaction volume surging and credit losses forecast below 1.75%. The company reconfirms FY26 guidance, underpinned by AI-driven underwriting and new subscription offerings.
Claire Turing
Claire Turing
7 May 2026
Arovella Therapeutics has named Dr Nicole Van Der Weerden as acting CEO following Dr Michael Baker’s departure, positioning her to steer the company through the critical phase I trial of its CAR-iNKT therapy ALA-101.
Ada Torres
Ada Torres
7 May 2026